INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 50 filers reported holding INSMED INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -99.3% | 3,000 | -99.3% | 0.00% | – |
| Q1 2022 | $427,000 | +4170.0% | 428,000 | +4180.0% | 0.00% | – |
| Q4 2021 | $10,000 | -99.8% | 10,000 | -99.8% | 0.00% | -100.0% |
| Q3 2021 | $5,729,000 | -42.4% | 5,538,000 | -41.8% | 0.00% | 0.0% |
| Q2 2021 | $9,940,000 | -16.4% | 9,517,000 | -10.9% | 0.00% | 0.0% |
| Q1 2021 | $11,893,000 | +160.1% | 10,685,000 | +127.1% | 0.00% | 0.0% |
| Q2 2020 | $4,572,000 | +904.8% | 4,704,000 | +763.1% | 0.00% | – |
| Q1 2020 | $455,000 | -92.1% | 545,000 | -92.1% | 0.00% | -100.0% |
| Q3 2019 | $5,751,000 | +52181.8% | 6,900,000 | +62627.3% | 0.00% | – |
| Q1 2019 | $11,000 | -15.4% | 11,000 | -42.1% | 0.00% | – |
| Q4 2018 | $13,000 | -99.9% | 19,000 | -99.8% | 0.00% | -100.0% |
| Q3 2018 | $9,231,000 | +46.5% | 10,966,000 | +59.8% | 0.00% | 0.0% |
| Q2 2018 | $6,300,000 | +10.9% | 6,862,000 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $5,679,000 | – | 6,459,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |